For example, inhibiting GPX4 activity has been shown to induce ferroptosis in hepatocellular carcinoma (HCC) cells (Wang Q. et al., 2021), and targeting GPX4 can alleviate ferroptosis and aid in the treatment of metabolism-related fatty liver disease (Tong et al., 2022). This evidence concerns the gene GPX4 and fatty liver disease.